In the imatinib group , the most common grade @-@ adverse events were hypophosphataemia ( @ -LSB- @ % -RSB- ) , anaemia ( @ -LSB- @ % -RSB- ) , abdominal pain ( @ ; @ % ) , and elevated lipase level ( @ ; @ % ) , and in the nilotinib group were anaemia ( @ ; @ % ) , elevated lipase level ( @ ; @ % ) , elevated alanine aminotransferase concentration ( @ ; @ % ) , and abdominal pain ( @ ; @ % ) .